✦ LIBER ✦

1089 Improved safety of capecitabine vs bolus 5-FU/leucovorin (LV) as adjuvant therapy for colon cancer (the X-ACT phase III study)

✍ Scribed by Nowacki, M.; Kröning, H.; Cervantes, A.; Husseini, F.; McKendrick, J.; Schuller, J.; Twelves, C.; Wong, A.; Zaluski, J.; Douillard, J.-Y.

Book ID: 123385727
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 164 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(03)91115-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

634 POSTER Post-study treatment does not

634 POSTER Post-study treatment does not influence outcome in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 141 KB

PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS

PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS ADJUVANT THERAPY FOR PATIENTS WITH DUKES' C COLON CANCER: PHARMACOECONOMIC EVALUATION OF X-ACT TRIAL– DATA FROM CZECH PERSPECTIVE

✍ L Jiraskova; T Dolezal 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

617 POSTER Initial safety findings from

617 POSTER Initial safety findings from XELOXA: a randomised phase III trial of capecitabine plus oxaliplatin vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with stage III colon cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 122 KB

1LB 5-year overall survival update from

1LB 5-year overall survival update from the X-ACT trial of capecitabine vs. 5-FU/LV as adjuvant treatment for stage-III colon cancer

✍ C. Twelves; W. Scheithauer; J. McKendrick; M. Nowacki; J. Seitz; G. Van Hazel; A 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 38 KB

5LBA First efficacy findings from a rand

5LBA First efficacy findings from a randomized phase III trial of capecitabine + oxaliplatin vs. bolus 5-FU/LV for stage III colon cancer (NO16968/XELOXA study)

✍ D. Haller; J. Tabernero; J. Maroun; F. de Braud; T. Price; E. Van Cutsem; M. Hil 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

675 PUBLICATION Economic evaluation of c

675 PUBLICATION Economic evaluation of capecitabine (X) vs. bolus 5-FU/LV as adjuvant chemotherapy for patients (pts) with Dukes' C colon cancer in an Italian hospital setting

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 146 KB